Last 12 months
Inside the activity.
11 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 3 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 3 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · derivative · entry 9 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 30,000 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F8 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $6.06 | $0.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · derivative · entry 8 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,000 shares Expires 2029-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F7 · derivative.exercise_date: The shares subject to the option vest in twenty-four equal monthly installments from the grant date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Stock | 10,000 | $30.55 | $305,500.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · nonDerivative · entry 5 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,299 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.30 to $30.80, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Stock | 90,000 | $31.17 | $2,805,300.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · nonDerivative · entry 4 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,299 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.00 to $31.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionCommon Stock | 30,000 | $5.30 | $159,000.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · nonDerivative · entry 3 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 187,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionCommon Stock | 70,000 | $6.06 | $424,200.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · nonDerivative · entry 2 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 21:18 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 50,000 | $30.17 | $1,508,500.00 |
DisclosureSEC source: 0001628280-21-023169 · wf-form4_163675187710828.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,861 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 09, 2021 Filed Nov 12, 2021 21:13 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Shares | 50,000 | $30.17 | $1,508,500.00 |
DisclosureSEC source: 0001628280-21-023153 · wf-form4_163675158142693.xml · nonDerivative · entry 1 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,299 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $30.00 to $30.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:24 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001628280-21-021484 · wf-form4_163597106564909.xml · derivative · entry 3 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 45,000 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F4 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:24 UTC |
Solomons NeilChief Medical Officer
|
SaleCommon Stock | 45,000 | $31.64 | $1,423,800.00 |
DisclosureSEC source: 0001628280-21-021484 · wf-form4_163597106564909.xml · nonDerivative · entry 2 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,299 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $31.50 to $31.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:24 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionCommon Stock | 45,000 | $5.30 | $238,500.00 |
DisclosureSEC source: 0001628280-21-021484 · wf-form4_163597106564909.xml · nonDerivative · entry 1 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:20 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001628280-21-021477 · wf-form4_163597080368439.xml · derivative · entry 3 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 45,000 shares Expires 2027-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F4 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:20 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 45,000 | $31.64 | $1,423,800.00 |
DisclosureSEC source: 0001628280-21-021477 · wf-form4_163597080368439.xml · nonDerivative · entry 2 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $31.50 to $31.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:20 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 45,000 | $3.20 | $144,000.00 |
DisclosureSEC source: 0001628280-21-021477 · wf-form4_163597080368439.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 20:33 UTC |
Huizinga Robert BindertEVP of Research
|
Exercise / conversionStock Option (right to buy) · Derivative | 95,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001628280-21-020527 · wf-form4_163528039067523.xml · derivative · entry 3 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,864 Underlying: Common Stock · 95,000 shares Expires 2027-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F4 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 20:33 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 130,000 | $29.75 | $3,867,500.00 |
DisclosureSEC source: 0001628280-21-020527 · wf-form4_163528039067523.xml · nonDerivative · entry 2 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,728 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $29.50 to $30.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 25, 2021 Filed Oct 26, 2021 20:33 UTC |
Huizinga Robert BindertEVP of Research
|
Exercise / conversionCommon Stock | 95,000 | $3.20 | $304,000.00 |
DisclosureSEC source: 0001628280-21-020527 · wf-form4_163528039067523.xml · nonDerivative · entry 1 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:53 UTC |
Huizinga Robert BindertEVP of Research
|
Exercise / conversionStock Option (right to buy) · Derivative | 11,136 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001628280-21-019051 · wf-form4_163234399960979.xml · derivative · entry 6 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,864 Underlying: Common Stock · 11,136 shares Expires 2027-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F6 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:53 UTC |
Huizinga Robert BindertEVP of Research
|
Exercise / conversionStock Option (right to buy) · Derivative | 16,000 | $0.00 Strike: $2.63 | $0.00 |
DisclosureSEC source: 0001628280-21-019051 · wf-form4_163234399960979.xml · derivative · entry 5 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,000 shares Expires 2022-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F5 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in three equal monthly installments from the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:53 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 5,364 | $23.66 | $126,912.24 |
DisclosureSEC source: 0001628280-21-019051 · wf-form4_163234399960979.xml · nonDerivative · entry 4 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,728 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.64 to $23.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:53 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 27,136 | $24.05 | $652,620.80 |
DisclosureSEC source: 0001628280-21-019051 · wf-form4_163234399960979.xml · nonDerivative · entry 3 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,092 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $24.02 to $24.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:53 UTC |
Huizinga Robert BindertEVP of Research
|
Exercise / conversionCommon Stock | 11,136 | $3.20 | $35,635.20 |
DisclosureSEC source: 0001628280-21-019051 · wf-form4_163234399960979.xml · nonDerivative · entry 2 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:53 UTC |
Huizinga Robert BindertEVP of Research
|
Exercise / conversionCommon Stock | 16,000 | $2.63 | $42,080.00 |
DisclosureSEC source: 0001628280-21-019051 · wf-form4_163234399960979.xml · nonDerivative · entry 1 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,092 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 10,000 | $0.00 Strike: $18.38 | $0.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · derivative · entry 11 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,900 Underlying: Common Stock · 10,000 shares Expires 2030-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F7 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 70,000 | $0.00 Strike: $6.06 | $0.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · derivative · entry 10 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 70,000 shares Expires 2029-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F8 · derivative.exercise_date: The shares subject to the option vest in twenty-four equal monthly installments from the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 7,500 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · derivative · entry 9 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F7 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 87,500 | $24.02 | $2,101,750.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 7 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $23.90 to $24.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 10,000 | $18.38 | $183,800.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 6 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 264,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 70,000 | $6.06 | $424,200.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 5 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 21, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 7,500 | $5.30 | $39,750.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 4 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 28,500 | $5.30 Strike: $5.30 | $151,050.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · derivative · entry 8 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 28,500 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F7 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 16,000 | $21.60 | $345,600.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 3 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in connection with a divorce settlement agreement. F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.56 to $21.61, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 12,500 | $21.71 | $271,375.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 2 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,861 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.70 to $21.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 20, 2021 Filed Sep 22, 2021 20:31 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 28,500 | $5.30 | $151,050.00 |
DisclosureSEC source: 0001628280-21-019048 · wf-form4_163234265014624.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,361 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 45,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · derivative · entry 8 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2027-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F8 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 45,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · derivative · entry 7 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 45,000 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F7 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Stock | 90,000 | $21.19 | $1,907,217.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · nonDerivative · entry 5 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in connection with a divorce settlement agreement. F5 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $21.00 to $21.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 45,000 | $3.20 | $144,000.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · nonDerivative · entry 4 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 45,000 | $5.30 | $238,500.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · nonDerivative · entry 3 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 14, 2021 Filed Sep 14, 2021 21:12 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 22,500 | $21.75 | $489,375.00 |
DisclosureSEC source: 0001628280-21-018595 · wf-form4_163165391729313.xml · nonDerivative · entry 3 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 106,092 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:01 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 44,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001628280-21-018782 · wf-form4_163182609831779.xml · derivative · entry 4 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,000 Underlying: Common Stock · 44,000 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F6 · derivative.exercise_date: The shares subject to the option vest in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:01 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 30,000 | $21.80 | $654,000.00 |
DisclosureSEC source: 0001628280-21-018782 · wf-form4_163182609831779.xml · nonDerivative · entry 3 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F4 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.75 to $21.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:01 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 14,000 | $21.73 | $304,220.00 |
DisclosureSEC source: 0001628280-21-018782 · wf-form4_163182609831779.xml · nonDerivative · entry 2 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,861 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in connection with a divorce agreement. F3 · price: The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $21.71 to $21.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:01 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Stock | 44,000 | $5.30 | $233,200.00 |
DisclosureSEC source: 0001628280-21-018782 · wf-form4_163182609831779.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionOption Grant (right to buy) · Derivative | 25,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · derivative · entry 6 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 25,000 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F6 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
Exercise / conversionCommon Shares | 25,000 | $5.30 | $132,500.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · nonDerivative · entry 1 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 21:11 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001628280-21-018594 · wf-form4_163165384671882.xml · derivative · entry 3 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 150,000 shares Expires 2027-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. F4 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. They vested in thirty-six equal monthly installments from the grant date. Read SEC document |
| September 13, 2021 Filed Sep 14, 2021 21:11 UTC |
Solomons NeilChief Medical Officer
|
Exercise / conversionCommon Shares | 150,000 | $3.20 | $480,000.00 |
DisclosureSEC source: 0001628280-21-018594 · wf-form4_163165384671882.xml · nonDerivative · entry 1 Solomons Neil · CIK 0001837720 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 287,299 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 22:16 UTC |
Martin Michael RobertChief Business Officer
|
SaleCommon Shares | 25,000 | $19.80 | $495,000.00 |
DisclosureSEC source: 0001628280-21-018603 · wf-form4_163165777007172.xml · nonDerivative · entry 2 Martin Michael Robert · CIK 0001837647 · Chief Business Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,861 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price in column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $19.76 to $19.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 21:12 UTC |
Huizinga Robert BindertEVP of Research
|
SaleCommon Stock | 5,000 | $19.76 | $98,800.00 |
DisclosureSEC source: 0001628280-21-018595 · wf-form4_163165391729313.xml · nonDerivative · entry 2 Huizinga Robert Bindert · CIK 0001837648 · EVP of Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,592 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.